Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2422 (LINC02422)

Target
LINC02422
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 2422 (LINC02422) is a human long intergenic non-coding RNA (lincRNA), meaning it is a non-protein-coding RNA transcript greater than 200 nucleotides in length and does not overlap protein-coding genes[1][3][7]. LINC02422 is registered in both NCBI Gene (Gene ID: 105369723) and Ensembl (ENSG00000255760)[1][3]. Long intergenic non-coding RNAs like LINC02422 commonly regulate gene expression by influencing chromatin structure, interacting with RNA-binding proteins, and modulating mRNA stability or transcription[5][7][9]. The specific functional role or pathological involvement of LINC02422 remains uncharacterized in the current literature, and there are no established small molecule or biologic drugs known to target it[1][3][5]. LINC02422 is not known to be a therapeutic target such as a receptor, enzyme, transporter, or similar molecule. Notes: - Biological functions listed (gene regulation, chromatin remodeling, etc.) are generalizable properties for lincRNAs as a class; there is no direct functional assignment to LINC02422 itself in currently available data[5][7][9]. - No disease association, biomarker application, or drug interaction has been specifically described for LINC02422 in public sources as of the current update[1][3]. - No evidence of misspelling or other metadata inaccuracies for LINC02422, but information is limited to genomic annotation; functional and clinical relevance is unconfirmed.

Other names
LINC02422LOC105369725
02

Biological functions

Potential gene expression regulationChromatin remodelingRNA stabilizationTranscriptional modulation
03

Disease associations

Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2422 (LINC02422).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2422 (LINC02422).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call